AFT Pharmaceuticals share price rallies to five-year high
AFT Pharmaceuticals' share price has reached levels not seen in five years, driven by investor optimism about its drug pipeline.
AFT Pharmaceuticals' share price has rallied to its highest level in five years, approaching the all-time high reached in late 2020. The rise follows management focus on the company's pipeline of drugs under development that show promising demand prospects pending regulatory approval and market entry.
Covered byBusinessDeskNot covered byRNZStuffNZ Herald1NewsNewstalk ZBOtago Daily TimesNewsroomThe Spinoffinterest.co.nz
Coverage across the news outlets we track, as at publication.
What outlets are saying
BusinessDesk
AFT Pharmaceuticals: Surfing the wave of investor optimism pushes
It’s taken five years, but hard graft combined with some jawboning over the past week, along with good luck, has seen AFT Pharmaceuticals’ share price rally to levels not seen for five years – putting it within spitting distance of…